Tram Tran - Nov 9, 2021 Form 4 Insider Report for Arbutus Biopharma Corp (ABUS)

Role
Director
Signature
/s/ David C. Hastings as attorney-in-fact for Tram Tran
Stock symbol
ABUS
Transactions as of
Nov 9, 2021
Transactions value $
$0
Form type
4
Date filed
11/12/2021, 05:22 AM
Next filing
May 26, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABUS Stock Option (Right to Buy) Award $0 +44K $0.00 44K Nov 9, 2021 Common Shares 44K $3.50 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on November 9, 2021, the date of the grant.
F2 The option will vest and become exercisable in three equal annual installments beginning one year from the grant date.